Your session is about to expire
β Back to Search
Neuro RX Gamma for Mild Cognitive Impairment
Study Summary
This trial will study the effects of transcranial near infrared light on the cognitive changes and neural correlates associated with Alzheimer's disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of stroke, seizures, MS, light sensitivity, or Lyme disease.I have a brain condition affecting my thinking, but it's not Alzheimer's.I have no issues with walking, seeing, or hearing that would affect my participation.I have had frequent nosebleeds in the last 6 months or am on strong blood thinners.I do not have any uncontrolled illnesses like diabetes or high blood pressure.I have a history of severe agitation, aggression, or seizures.I am currently receiving light therapy treatment.I have been on a stable dose of cholinesterase inhibitors or memantine for the last 3 months.I am 50 years old or older.
- Group 1: Active Neuro Rx Device
- Group 2: Sham Neuro Rx Device
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the protocol for this medical study extend to octogenarians?
"This research project is looking for elderly participants aged 50 and above, but not exceeding 95 years of age."
What objectives are the researchers hoping to fulfill with this experiment?
"The primary outcome measure of this experiment, which will be observed at the Baseline and 6 weeks post randomization intervals, is changes in visuospatial memory as assessed by the BVMT-R. Secondary objectives include alterations to cortical thickness, subcortical volume, mild behavioural impairment checklist ratings, blood lactate levels/lactate/pyruvate ratio over time - all surrogate markers for mitochondrial function."
Does this clinical research currently accept participants?
"According to the information provided on clinicaltrials.gov, this medical study has concluded its recruitment period and is no longer actively seeking patients. This trial was initially posted on October 15th 2022 and last updated September 28th 2022. Nonetheless, there are 591 other trials that are still recruiting subjects at present time."
Am I eligible to volunteer for this medical experiment?
"To be eligible for participation, candidates must have mild cognitive disorder and fall between the ages of 50 to 95 years old. This particular trial is recruiting approximately 20 individuals."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger